Bronte Capital Management Pty Ltd. Decreases Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Bronte Capital Management Pty Ltd. decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 0.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 281,528 shares of the financial services provider’s stock after selling 1,701 shares during the period. iShares Biotechnology ETF makes up about 3.7% of Bronte Capital Management Pty Ltd.’s holdings, making the stock its 11th biggest holding. Bronte Capital Management Pty Ltd. owned approximately 0.51% of iShares Biotechnology ETF worth $38,246,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the business. International Assets Investment Management LLC purchased a new position in iShares Biotechnology ETF during the 4th quarter valued at about $76,425,000. Itau Unibanco Holding S.A. bought a new stake in shares of iShares Biotechnology ETF during the 3rd quarter valued at about $48,242,000. Tower Research Capital LLC TRC raised its stake in iShares Biotechnology ETF by 28,138.4% in the third quarter. Tower Research Capital LLC TRC now owns 98,552 shares of the financial services provider’s stock worth $12,052,000 after buying an additional 98,203 shares in the last quarter. Calamos Advisors LLC purchased a new stake in iShares Biotechnology ETF in the fourth quarter worth about $7,648,000. Finally, abrdn plc bought a new stake in iShares Biotechnology ETF during the 4th quarter valued at approximately $5,928,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 0.6 %

Shares of NASDAQ:IBB traded up $0.83 during trading on Thursday, hitting $133.42. The stock had a trading volume of 981,442 shares, compared to its average volume of 1,783,524. The firm’s fifty day moving average is $133.20 and its 200 day moving average is $130.36. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $141.16.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were paid a dividend of $0.126 per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 annualized dividend and a yield of 0.38%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.